Market Cap (In USD)
5324.00
Revenue (In USD)
-
Net Income (In USD)
-2.24 Million
Avg. Volume
255.00
- Currency
- USD
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 8.0E-4-0.45
- PE
- -
- EPS
- -
- Beta Value
- 0.064
- ISIN
- US30051F1012
- CUSIP
- 30051F101
- CIK
- 884363
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Mr. Steve B. Warnecke
- Employee Count
- -
- Website
- https://www.evolgen.com
- Ipo Date
- 2012-05-15
- Details
- Evolutionary Genomics, Inc., together with its subsidiaries, engages in the research and identification of positively selected genes in humans, animals, and commercial crops. The company develops Adapted Traits Platform, a technology platform to identify genes for enhancing crop plant traits, such as yield, sugar content, biomass, drought tolerance, and pest/disease resistance. It serves governmental organizations, non-profit foundations, and commercial entities. Evolutionary Genomics, Inc. was incorporated in 1990 and is based in Castle Rock, Colorado.
More Stocks
-
INGERRANDIngersoll-Rand (India) Limited
INGERRAND
-
3369
-
600449
-
MFRVF
-
2722I.K Co., Ltd.
2722
-
603787
-
MARGOFINMargo Finance Limited
MARGOFIN
-
ILST